Clinical study
Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults

https://doi.org/10.1016/S0002-9343(97)89493-4Get rights and content

Purpose

To assess the efficacy, dose stability, safety, and abuse potential of long-term, nightly benzodiazepine treatment of chronic disorders of disrupted nocturnal sleep.

Patients and methods

During a 12-year period, one author evaluated and treated 170 adult referrals for ≥6 months with nightly benzodiazepine therapy for longstanding, sleep-disruptive disorders: injurious sleepwalking and sleep terrors (69); rapid eye movement sleep behavior disorder (52); chronic, severe insomnia (25); and restless legs syndrome/periodic limb movement disorder (24).

Results

Complete/substantial control of the sleep disorders was achieved by 146 patients (86%); 8% had adverse effects requiring medication changes; 2% had relapses of alcohol or chemical abuse requiring hospitalization; another 2% at times misused their medications. A total of 136 patients received clonazepam nightly for a mean 3.5 (± 2.4) years, with no significant difference in initial versus final mean dose: 0.77 mg (± 0.46) versus 1.10 mg (± 0.96). Similar results were obtained with chronic alprazolam treatment and with other benzodiazepine treatments.

Conclusion

Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep resulted in sustained efficacy in most cases, with low risk of dosage tolerance, adverse effects, or abuse. Data from this study on the treatment of chronic, severe insomnia (a small subset of all insomnia) are not generalizable to the typical insomnia patient.

References (27)

  • BlouinAG et al.

    Computerized administration of the diagnostic interview schedule

    Psychiatry Res

    (1988)
  • BeckAT et al.

    Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation

    Clin Psychol Rev

    (1988)
  • RegesteinQR et al.

    Incapacitating childhood onset insomnia

    Compr Psychiatry

    (1983)
  • WoodsJH et al.

    Abuse liability of benzodiazepines

    Pharmacol Rev

    (1987)
  • WoodsJH et al.

    Use and abuse of benzodiazepines: issues relevant to prescribing

    JAMA

    (1988)
  • UhlenhuthEH et al.

    Risks and benefits of long-term benzodiazepine use

    J Clin Psychopharmacol

    (1988)
  • WoodsJH et al.

    Benzodiazepines: use, abuse, and conse-quences

    Pharmacol Rev

    (1992)
  • American Psychiatric Association

    Benzodiazepine dependence, toxicity, and abuse: a task force report of the American Psychiatric Association

    (1990)
  • SchenckCH et al.

    A polysomnographic, neurologic, psychiatric and clinical outcome report on 70 consecutive cases with REM sleep behavior disorder (RBD): sustained clonazepam efficacy in 89.5% of 57 treated patients

    Cleve Clin J Med

    (1990)
  • SchenckCH et al.

    A polysomnographic and clinical report on sleep-related injury in 100 adult patients

    Am J Psychiatry

    (1989)
  • American Psychiatric Association
  • DerogatisLR
  • RechtschaffenA et al.
  • Cited by (276)

    • Sleep Terrors

      2024, Sleep Medicine Clinics
    • Temporomandibular Joint Surgery

      2023, Journal of Oral and Maxillofacial Surgery
    • Value of polysomnography and other diagnostic tools to diagnose and treat parasomnias

      2023, Encyclopedia of Sleep and Circadian Rhythms: Volume 1-6, Second Edition
    • Sleep terrors

      2023, Encyclopedia of Sleep and Circadian Rhythms: Volume 1-6, Second Edition
    • REM sleep behavior disorder

      2023, Encyclopedia of Sleep and Circadian Rhythms: Volume 1-6, Second Edition
    View all citing articles on Scopus
    View full text